osteoclastogenesis inhibitors (National Taiwan University/China Medical University/National Cheng Kung University)

N/A

Report date: 2025/03/20 14:43:40
NME

Base Information

Drug Nameosteoclastogenesis inhibitors (National Taiwan University/China Medical University/National Cheng Kung University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOsteoclasts inhibitors
TargetsUpdating
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Taiwan University
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A